GLP-1 drugs reduce risk of major adverse cardiovascular events
New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.
another news portal
New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.
Thousands of patients will be offered a new injectable form of an immunotherapy drug that takes minutes.
The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic
A multidisciplinary medical team in Peru successfully managed an ectopic pregnancy in which a placenta adhered to the mother’s liver was delivered as a full-term
Trust in MAHA leaders has justifiably collapsed, and the sycophants who previously glorified Dr. Jay Bhattacharya have mysteriously vanished, unwilling to even acknowledge what they
A maker of the widely used abortion pill mifepristone has asked the Supreme Court to block a lower court’s ruling cutting off mail-order access to
A Nature study reports a single-molecule GLP-1–GIP–lanifibranor quintuple agonist that targets incretin receptor-expressing cells while activating PPARα/γ/δ pathways. In obese and insulin-resistant mice, the compound
A new study shows that how a cell fails to divide after copying its DNA can determine its fate.
A gentler treatment for children whose leukemia has come back could boost survival and quality of life, a study led by a UCL academic has
CAR T-cell therapy has transformed the treatment of hematologic malignancies, yet many patients do not achieve lasting benefit – often because the infused cells fail
Researchers at the Garvan Institute of Medical Research have uncovered a critical mechanism driving inflammation in mevalonate kinase deficiency (MKD), a rare but devastating autoinflammatory
Death doulas or soul midwives have increased in popularity in recent years. What do they do?
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
Chemotherapy-induced pancytopenia remains a serious challenge in cancer care because falling blood counts can lead to treatment delays and dose reductions, with associated impact on